Clinical Trial Detail

NCT ID NCT03525795
Title ORIOn-E: A Study Evaluating CPI-1205 in Patients With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Constellation Pharmaceuticals
Indications

melanoma

lung non-small cell carcinoma

renal cell carcinoma

transitional cell carcinoma

Advanced Solid Tumor

Therapies

CPI-1205 + Ipilimumab

Age Groups: adult senior

No variant requirements are available.